Zoom in on boards, committees and incentives that make—or break—value creation.

• Principal–agent conflicts & classic agency costs.
• Audit, nom-gov & comp committees—what great ones do daily.
• Activism, poison pills, dual-class shares: protecting or harming owners?
• Governance failures (Theranos, Dieselgate) and the lessons analysts track.